Novo Nordisk | NVO - PE Price to Earnings

Stock Price
44.31
Daily Change
-1.53 -3.34%
Monthly
8.39%
Yearly
-31.15%
Q2 Forecast
42.62

Novo Nordisk reported 13.92 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
ANI Pharmaceuticals 27.31 10.68 Mar/2026
Aurora Cannabis 23.27 0 Sep/2025
Bausch Health Companies 6.98 0.41 Dec/2025
Bristol-Myers Squibb 9.08 0.2 Mar/2026
Corcept Therapeutics 113.58 71.67 Mar/2026
Drreddys Laboratories 18.27 0.84 Dec/2025
Eli Lilly 40.27 0.06 Mar/2026
GlaxoSmithKline 14.87 3.72 Mar/2026
Merck 16.52 2.6 Mar/2026
Novartis 20.17 2.32 Mar/2026
Novo Nordisk 12.78 0.01 Dec/2025
Novo Nordisk 13.92 4.91 Sep/2025
Pacira 38.58 14.1 Mar/2026
Perrigo 27.45 31.51 Mar/2026
Phibro Animal Health 13.82 4.04 Dec/2025
Prestige Brands 15.31 3.1 Dec/2025
Sanofi 11.84 0.14 Mar/2026
Supernus Pharmaceuticals 44.21 66.17 Mar/2026
Zoetis 18.8 1.62 Mar/2026